Connect with us

World News

COVID-19 vaccine side effects: What to know

Published

on

115368367 vaccine2

The news about the coronavirus vaccine has been positive lately. Many health care workers around the country received their first dose of the Pfizer-BioNTech vaccine after it acquired emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) on Dec. 11. A second vaccine, from biotech firm Moderna, is on the cusp of clearing the same regulatory hurdle, and if all goes as expected, as many as 20 million Americans could be vaccinated against COVID-19 before the end of the year.

While it may take a while for production to ramp up to the point where a vaccine is readily available to the general public, health experts say there is one thing that’s critical for people to understand before they roll up their sleeves for the shots: The vaccines may cause side effects. According to the FDA, the most common side effects among participants in both the Pfizer-BioNTech and Moderna phase 3 clinical trials were:

  • Injection site pain
  • Fatigue
  • Headache
  • Muscle pain
  • Chills
  • Joint pain
  • Fever   

However, these reactions are “temporary,” and they “self-resolve” within a few days, says Wilbur Chen, M.D., a professor of medicine and chief of adult clinical studies at the Center for Vaccine Development and Global Health at the University of Maryland. Even so, it’s “ultracritical” that health experts are transparent with the public about what to expect.

“Where a mistake could be made is in people being surprised or not being prepared for side effects,” adds William Moss, M.D., executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.

Transparency builds trust

One reason: public trust. Polls show that as many as 42 percent of Americans say they are unwilling to get a coronavirus vaccine when one becomes available, for reasons spanning the unprecedented speed of the vaccines’ development to a general mistrust of vaccines. People are also concerned about potential side effects from the shots, according to a recent Pew Research Center survey, making it “critically important” for health experts to be upfront about all the possibilities, Moss argues.

Another reason people need to know about any potential side effects: Both the Pfizer-BioNTech and Moderna vaccines require two doses, given a few weeks apart. And unanticipated side effects from the first shot could deter people from going back for the second, which is needed to “get the most protection the vaccine has to offer,” the Centers for Disease Control and Prevention (CDC) points out.

Advertisement

“We don’t know what happens after a single dose,” Moss says. “Certainly we can’t expect [that one dose will confer] the high degree of protection” that both doses demonstrated in phase 3 clinical trials. (Pfizer’s vaccine, for example, was found to be about 52 percent effective after the first dose; effectiveness jumped to 95 percent after the second.)

“So it’s really important that people get two doses and not be thrown off or discouraged,” Moss adds.

Finally, knowing that a sore arm or a fever is a possible side effect helps ease public alarm, says Hana El Sahly, M.D., associate professor of molecular virology and microbiology at Baylor College of Medicine. If someone experiences an unpleasant, but expected, response, “they can take some symptomatic treatment and have reassurance and minimize their anxiety around the vaccine,” she explains.

Side effects are not unique to COVID-19 vaccine

Side effects from vaccines are not uncommon. The seasonal flu shot, for example, can cause fever and fatigue, among other reactions. And the vaccine to prevent shingles can induce shivering, muscle pain and an upset stomach, to name a few.

In some ways, these mild to moderate reactions are “a good thing,” Moss says, because “it’s a sign that the immune system is responding to the vaccine.” Nevertheless, they shouldn’t be downplayed. For some people, a sore arm “is a big deal,” Chen points out. Reactions from the coronavirus vaccine may even cause recipients to miss a day or two of work.

Advertisement

The key, experts say, is to weigh the temporary discomfort against the long-term benefits: a potentially high level of protection from a disease that has uprooted everyday life for many of us and has killed more than 1.6 million people globally.

“We are willing to tolerate discomfort in other aspects of our life — many people exercise and have muscle aches afterward, and don’t say, ‘I’m never going to exercise again,’ ” Moss points out. “There are just many aspects of our lives where we need to be willing to make the trade-off for some degree of discomfort for a longer-term gain.”

It’s also important to keep in mind that the majority of reactions occur shortly after vaccination, so “there is a degree of reassurance” that the side effects reported in the clinical trials are likely the extent of any unpleasant short-term reactions, El Sahly says.

Older adults could experience fewer side effects

An interesting finding from the Pfizer-BioNTech and Moderna clinical trials is that while the vaccines seem to be just as effective in older adult participants, people 65 and older experienced fewer side effects than younger volunteers.

Researchers are still studying why this is the case, but it could have something to do with the declining immune response that comes with age. Because the coronavirus vaccine can provoke “a little bit of an inflammatory response,” Chen says, it may be that older adults react less to the medicine if they have “a blunted immune response already.”

Advertisement

Reports of a few adverse events

Federal analyses of both vaccine trials show that few adverse events — which the CDC defines as any health problem that happens after a shot — separate from the less serious side effects were reported. Swollen lymph nodes (lymphadenopathy) occurred in a small portion of the participant population. And four people who received Pfizer’s vaccine and three who received Moderna’s developed Bell’s palsy, which, in most cases, causes temporary weakness or paralysis in the face.

FDA scientists have said that the documented cases of Bell’s palsy are “consistent with the expected background rate in the general population” and that “currently available information is insufficient to determine a causal relationship [between Bell’s palsy and] the vaccine.” However, the situation is worth monitoring, health experts say.

What’s more, since the start of Pfizer’s vaccine rollout, two people in Great Britain and one person in Alaska have experienced severe allergic reactions after being vaccinated. The FDA is warning health care providers not to administer the Pfizer-BioNTech vaccine to individuals with a known history of a severe allergic reaction to any component of the product.

It’s important to keep in mind that these reactions, though serious, are relatively rare, seeing how tens of thousands of people have been inoculated with one of the two vaccines. “It’s a warning for a very small number of people,” says Barry Bloom, professor of public health in the department of immunology and infectious diseases at Harvard’s T.H. Chan School of Public Health.

If you’re concerned that your allergies could trigger a severe reaction to a coronavirus vaccine, talk to your doctor. And consider getting your vaccine in a medical setting, in case you do react.

Advertisement

“Most people can get the vaccine at pharmacies or a variety of different places. For people who’ve had allergic reactions, it’s a reason why they should talk to their doctor first — they [may] want to go to a place that’s more equipped for serious allergic reaction,” Karyl Rattay, director of the Delaware Division of Public Health, said in a recent news conference.

Safety monitoring doesn’t stop when vaccines become available

Just because the vaccines have expanded from trial participants to the public doesn’t mean monitoring for them will stop. Individuals who receive the vaccines will continue to be watched for long-term side effects and adverse events or disease. This follow-up will also give researchers more information on how long immunity to COVID-19 lasts after vaccination.

Something else that won’t stop when the vaccines are rolled out: the recommendation that people continue the prevention efforts that can help slow the spread of the disease, including mask wearing, social distancing and frequent handwashing. That’s because it typically takes a few weeks for the body to build immunity to a disease after vaccination, according to the CDC, meaning it’s possible you can get sick with COVID-19 even after you’ve been vaccinated. Plus, experts still aren’t sure whether the vaccines, which are highly effective at preventing COVID-19, block transmission of the virus.

Finally, it takes time to build up what Chen calls “community immunity,” or herd immunity, where enough of the population is protected from the virus that transmission slows significantly. Experts are not sure what the magic number is to obtain herd immunity for COVID-19, but they estimate it’s somewhere around 70 percent of the population, which could take months to achieve through vaccination.

Source: AARP

Advertisement
Advertisement

World News

Major step in malaria prevention as three West African countries roll out vaccine 

Published

on

malaria vaccine scaled

In a significant step forward for malaria prevention in Africa, three countries—Benin, Liberia and Sierra Leone—today launched a large-scale rollout of the life-saving malaria vaccine targeting millions of children across the three West African nations. The vaccine rollout, announced on World Malaria Day, seeks to further scale up vaccine deployment in the African region.

Today’s launch brings to eight the number of countries on the continent to offer the malaria vaccine as part of the childhood immunization programmes, extending access to more comprehensive malaria prevention. Several of the more than 30 countries in the African region that have expressed interest in the vaccine are scheduled to roll it out in the next year through support from Gavi, the Vaccine Alliance, as efforts continue to widen its deployment in the region in coordination with other prevention measures such as long-lasting insecticidal nets and seasonal malaria chemoprevention.

Benin, which received 215 900 doses, has added the malaria vaccine to its Expanded Programme on Immunization. The malaria vaccine should be provided in a schedule of 4 doses in children from around 5 months of age.

“The introduction of the malaria vaccine in the Expanded Programme on Immunization for our children is a major step forward in the fight against this scourge. I would like to reassure that the malaria vaccines are safe and effective and contribute to the protection of our children against this serious and fatal diseases,” said Prof Benjamin Hounkpatin, Minister of Health of Benin.

In Liberia, the vaccine was launched in the southern Rivercess County and will be rolled out afterwards in five other counties which have high malaria burden. At least 45 000 children are expected to benefit from the 112 000 doses of the available vaccine.

Advertisement

“For far too long, malaria has stolen the laughter and dreams of our children. But today, with this vaccine and the unwavering commitment of our communities, healthcare workers and our partners, including Gavi, UNICEF and WHO, we break the chain. We have a powerful tool that will protect them from this devastating illness and related deaths, ensuring their right to health and a brighter future. Let’s end malaria in Liberia and pave the way for a healthier, more just society,” said Dr Louise Kpoto, Liberia’s Minister of Health.

Two safe and effective vaccines — RTS,S and R21 — recommended by World Health Organization (WHO), are a breakthrough for child health and malaria control. A pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over 2 million children from 2019 to 2023, showing a significant reduction in malaria illness and a 13% drop in overall child mortality and substantial reductions in hospitalizations.

In Sierra Leone, the first doses were administered to children at a health centre in Western Area Rural where the authorities kicked off the rollout of 550 000 vaccine doses. The vaccine will then be delivered in health facilities nationwide.

“With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,” said Dr Austin Demby, Minister of Health of Sierra Leone.

Malaria remains a huge health challenge in the African region, which is home to 11 countries that carry approximately 70% of the global burden of malaria. The region accounted for 94% of global malaria cases and 95% of all malaria deaths in 2022, according to the World Malaria Report.

Advertisement

“The African region is taking positive steps in scaling up the rollout of the malaria vaccine – a game-changer in our fight against this deadly disease,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “Working with our partners, we’re committed to supporting the ongoing efforts to protect, save the lives of young children and lower the malaria burden in the region.”

Aurelia Nguyen, Chief Programme Officer at Gavi, the Vaccine Alliance, noted: “Today we celebrate more children gaining access to a new lifesaving tool to fight one of Africa’s deadliest diseases. This introduction of malaria vaccines into routine programmes in Benin, Liberia, and Sierra Leone alongside other proven interventions will help save lives and offer relief to families, communities and hard-pressed health systems.”

Progress against malaria has stalled in these high-burden African countries since 2017 due to factors including climate change, humanitarian crises, low access to and insufficient quality of health services, gender-related barriers, biological threats such as insecticide and drug resistance and global economic crises. Fragile health systems and critical gaps in data and surveillance have compounded the challenge.

To put malaria progress back on track, WHO recommends robust commitment to malaria responses at all levels, particularly in high-burden countries; greater domestic and international funding; science and data-driven malaria responses; urgent action on the health impacts of climate change; harnessing research and innovation; as well as strong partnerships for coordinated responses. WHO is also calling attention to addressing delays in malaria programme implementation.

Advertisement
Continue Reading

World News

Kid Cudi cancels tour after breaking foot at Coachella

Published

on

cudi

Kid Cudi has been forced to cancel his tour after breaking his foot at Coachella over the weekend. During the fest’s Weekend Two on Sunday night, the rapper went to the hospital with a broken foot after jumping off the stage at the Sahara Tent. (more…)

Continue Reading

World News

The Un Certain Regard Jury of the 77th Festival de Cannes

Published

on

Screenshot 2024 04 24 at 17.36.21

The Canadian actor, director, screenwriter and producer Xavier Dolan will be the President of the Un Certain Regard Jury of the 77th Festival de Cannes. He will be joined by French-Senegalese screenwriter and director Maïmouna Doucouré, Moroccan director, screenwriter and producer Asmae El Moudir, German-Luxembourg actress Vicky Krieps, and American film critic, director, and writer Todd McCarthy. They will be in charge of awarding prizes for the Un Certain Regard section, which showcases art and discovery films by young auteurs.

This year, 18 films have been selected, including 8 first films. The 2023 Un Certain Regard top prize went to director Molly Manning Walker’s debut feature How to Have Sex.

When the light breaks by Rúnar Rúnarsson will open the Un Certain Regard section on Wednesday May 15, 2024.

XAVIER DOLAN – President
Actor, director, screenwriter, producer
Canada

mail?url=https%3A%2F%2F0lvw3.mjt.lu%2Fimg2%2F0lvw3%2F70dda188 c9f8 4561 9f82 28159dd5c115%2Fcontent&t=1713979132&ymreqid=a9118f68 f99b 17f2 1c3c ba009f01b000&sig=JWkhMr

© Shayne Laverdière

An actor since the age of four, Xavier Dolan directed and starred in his first feature film, I killed my mother, which was a big hit at the Directors’ Fortnight in 2009. This was followed by Heartbeats and Laurence Anyways, presented at the Festival de Cannes in 2010 and 2012 at Un Certain Regard, where they were enthusiastically received. In 2013, Tom at the Farm was screened at the Venice Film Festival, where it won the FIPRESCI Prize. With Mommy, he is awarded several prizes, including the Prix du Jury at the 2014 Festival de Cannes and the César for Best Foreign Film. Grand Prize winner at the 2016 Festival de Cannes with It’s only the end of the World, he returns to Competition with Matthias & Maxime in 2019. After a few notable roles with other filmmakers, such as his performance in Xavier Giannoli’s Lost Illusions in 2021, for which he was nominated for a César for Best Supporting Actor, in 2022 he directed the series The Night Logan woke up. Xavier Dolan was a member of the Jury in 2015, and now chairs the Un Certain Regard Jury.

Advertisement

MAÏMOUNA DOUCOURÉ
Screenwriter, director
France, Senegal

mail?url=https%3A%2F%2F0lvw3.mjt

© Sacha Meric

Her first professional short film, Maman(s), was selected for nearly 200 festivals around the world and won more than 60 awards, including the Jury Prize at Sundance, the Best Film Award in Toronto and the 2017 César for Best Short Film. In 2019, Maïmouna Doucouré receives the Gold Fellowship Award from the Academy of Motion Pictures. Released in 2020, Cuties, her first feature film, wins the Best Director Award at Sundance and a Special Mention from the International Generation Jury in Berlin. The film’s lead actress, Fathia Youssouf, won the César for Best Actress. Her second feature-length film, Hawa, produced in 2022 with Prime Vidéo, was also presented in Toronto. Maïmouna Doucouré is currently working on her next feature film about the legendary Joséphine Baker.

ASMAE EL MOUDIR
Director, screenwriter, producer
Morocco

mail?url=https%3A%2F%2F0lvw3.mjt

© Ammar Abd Rabbo

Asmae El Moudir studied cinema at the Moroccan University and at La Fémis in Paris. She has directed several award winning short films. She completed her Al Jazeera television documentary, The Postcard, in 2020. The Mother of all Lies is her first independent documentary feature premiered at the 2023 Festival de Cannes where it won the Un Certain Regard Directing Prize. The film also won the Golden Eye for Best Documentary. The film is screened at Toronto, Sundance, Melbourne, Busan, Karlovy Vary as well as many festivals around the world and won more than 25 awards. Asmae El Moudir is nominated for the PGA Award and the Film Independent Spirit Award for Best Doc. Most recently, she won the IDA Award (International Documentary Association) for Best Director. The Mother of All Lies was also shortlisted in the international features section of the Oscars 2024.

VICKY KRIEPS
Actress
Luxembourg, Germany

Advertisement
mail?url=https%3A%2F%2F0lvw3.mjt.lu%2Fimg2%2F0lvw3%2F21ce48f8 6b1f 423e b3fd a88a13e85c4f%2Fcontent&t=1713979132&ymreqid=a9118f68 f99b 17f2 1c3c

© Virgile Guinard

An international actress who works in French, English and German, Vicky Krieps has appeared in Joe Wright’s Hannah (2011), Philippe Claudel’s Before the Winter Chill(2013), Anton Corbijn’s  A most wanted Man(2014), Ingo Haeb’s The Chambermaid Lynn(2015), Raoul Peck’s The Young Karl Marx(2017), and starred alongside Daniel Day Lewis in Paul Thomas Anderson’s Phantom Thread(2017). In 2021, she defended two films selected for the Festival de Cannes, Mia Hansen-Løve’s Bergman Island in Competition and Mathieu Amalric’s Hold me tight. The following year, she returned with two young German and Austrian directors in the Un Certain Regard section: Emily Atef’s More than Ever and Marie Kreutzer’s Corsage, which won her the Un Certain Regard Jury’s Best Actress Award in 2022. She will soon be seen in Viggo Mortensen’s The Dead Don’t Hurt and Hot Milkby Rebecca Lenkiewicz.

TODD MCCARTHY
Film critic, director, writer
United States

mail?url=https%3A%2F%2F0lvw3.mjt

© Rebecca Sapp

Todd McCarthy is a Cannes veteran – his first was in 1970 – who for decades covered the Festival for Variety and The Hollywood Reporter. Among his books are the definitive biography “Howard Hawks: The Grey Fox of Hollywood”, “Kings of the Bs: Working Within the Hollywood System” and “Fast Women” about female race car drivers. He won an Emmy Award for his documentary Preston Sturges: The Rise and Fall of a Hollywood Genius and is currently working on a project set in Hollywood just after World War II.

 

Advertisement
Continue Reading

World News

Kanye West reportedly planning to launch porn studio

Published

on

e05c55400df81413497d59660b7eca67

Looks like Kanye West’s religious era is officially over. (more…)

Continue Reading

World News

Additions to the selection of the 77th Festival de Cannes

Published

on

CANNES

As announced at the press conference on April 11, here are the films that complete the Official Selection 2024.

UN CERTAIN REGARD

 

WHEN THE LIGHT BREAKS
Rúnar Rúnarsson

NIKI
Céline Sallette
1st film

FLOW
Gints Zilbalodis

Advertisement

When the light breaks by Rúnar Rúnarsson will open the Certain Regard section on Wednesday May 15.

CANNES PREMIERE

 

VIVRE, MOURIR, RENAITRE
Gaël Morel

MARIA
Jessica Palud

SPECIAL SCREENINGS

Advertisement
 

SPECTATEURS
Arnaud Desplechin

NASTY
Tudor Giurgiu

LULA
Oliver Stone

AN UNFINISHED FILM
Lou Ye

OUT OF COMPETITION

Advertisement
 

LE COMTE DE MONTE-CRISTO
Alexandre De La Patellière et Matthieu Delaporte

COMPETITION

 

LA PLUS PRÉCIEUSE DES MARCHANDISES
Michel Hazanavicius

TREI KILOMETRI PANA LA CAPATUL LUMII
(Trois kilomètres jusqu’à la fin du monde)
Emanuel Parvu

THE SEED OF THE SACRED FIG
Mohammad Rasoulof

Advertisement
Continue Reading

World News

Eminem celebrates 16 years of sobriety

Published

on

Eminem 695x500 1

Eminem is celebrating 16 years of sobriety. (more…)

Continue Reading

Trending